Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

The Danish drugmaker Novo Nordisk announced it has temporarily reduced the price of the weight-loss drug Wegovy ... the shortages of Wegovy and Eli Lilly's Zepbound are over.

The MUSC Weight Management Center (WMC) is casting a lifeline to plus-sized individuals at wit's end with their apple cider ...

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy ... and 43% split doses over a longer period.

Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo ... Journal of Medicine over the weekend and simultaneously ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide ... 25% body weight loss compared to ...